Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
MYEOV, also named as OCIM, was originally isolated by the application of the NIH/3T3 tumorigenicity assay with DNA from a gastric carcinoma. It is a prognostic factor for patients with multiple myeloma, in part through a role of MYEOV in the control of MMC proliferation. MYEOV is a candidate oncogene activated in the amplification core located proximal toCCND1.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: myeloma overexpressed (in a subset of t(11;14) positive multiple myelomas); myeloma overexpressed gene (in a subset of t(11;14) positive multiple myelomas); Myeloma-overexpressed gene protein; Oncogene in multiple myeloma
基因别名: MYEOV; OCIM
UniProt ID: (Human) Q96EZ4
Entrez Gene ID: (Human) 26579